Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States
Authors
Keywords
-
Journal
NEUROMODULATION
Volume 19, Issue 7, Pages 689-697
Publisher
Wiley
Online
2016-08-05
DOI
10.1111/ner.12474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial
- (2016) Emma McIntosh et al. MOVEMENT DISORDERS
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease?
- (2014) M.G. Rizzone et al. PARKINSONISM & RELATED DISORDERS
- The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease
- (2013) Simon Eggington et al. JOURNAL OF NEUROLOGY
- Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease
- (2013) Judith Dams et al. MOVEMENT DISORDERS
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Parkinson's disease medication use and costs following deep brain stimulation
- (2012) Frances M. Weaver et al. MOVEMENT DISORDERS
- Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
- (2012) F. M. Weaver et al. NEUROLOGY
- Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study
- (2012) Günther Deuschl et al. PARKINSONISM & RELATED DISORDERS
- Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease
- (2011) Maurizio Zibetti et al. MOVEMENT DISORDERS
- A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK
- (2011) Julia Lowin et al. JOURNAL OF MEDICAL ECONOMICS
- Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
- (2010) A. Fasano et al. BRAIN
- A Longitudinal Analysis of Total 3-Year Healthcare Costs for Older Adults Who Experience a Fall Requiring Medical Care
- (2010) Alex A. Bohl et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
- (2010) Ying Jiao Zhao et al. MOVEMENT DISORDERS
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
- (2010) Kenneth A. Follett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial
- (2009) Frances M. Weaver JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interpreting the Results of Cost-Effectiveness Studies
- (2008) David J. Cohen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started